Skip to content

CHECKED

Create an account

Search

Companies

Search companies
Addresses
Company groups
Nearby
Service voucher comparison

People and firms

Directors
Bankruptcy trustees
Notaries

Events

Events: Overview
All events

Company changes

Incorporations
Director changes
Name changes
Registered office moves
Mergers and takeovers

Financial publications

Annual accounts filed
Capital changes
Auditor changes

Legal status & closure

Bankruptcies
Judicial reorganisations
Dissolutions and liquidations
Ex-officio strike-offs
Interim measures

Tools

Tools: Overview

Investigate

Analysis workbench
Compare companies
Sector benchmark
Employer check
Network investigator
Company wealth map
Lookalike companies
Company as of a date
Permit applications

Assess companies

Credit check
Supplier due diligence
AML client file
Creditor guide
Contractor check
Self-check
Public procurement exclusion grounds
Service voucher comparison

Market and sector

Sector figures
Municipality map
Subsidies
Market analysis
Trends
Rankings
Survival tables
Public contracts

Invoices and lists

Invoice check
Peppol check
Process a list

Starting out

Name check
Local market research
Starter mirror
Financial plan

Sign in

NL FR EN

EN

Nederlands Français English

My Checked

Sign in
Create an account

Home / Tools / Value indication / PHARMACLIC ASSETS

PHARMACLIC ASSETS: value indication

Sector benchmark
What changed
Value indication

Checked · Insight, alerts and connections for every Belgian company, from official sources.

Based on official Belgian registers and filed annual accounts.

NL FR EN

Discover

All tools Sector figures Rankings Municipality map All events Company groups Trends Survival tables

Checked

About Checked Contact Pricing

Help and guides

Frequently asked questions Knowledge base

Integrations

API AI assistants Excel and Google Sheets Company badge

Legal

Privacy policy Terms of service Cookies

We would like to set cookies. That happens only with your consent. What we measure

Help us improve Checked

If something looks wrong or is missing, please tell us.

Your message Email (optional, only to reply)

Line	Code	2023	2024	Change	%
Total assets	20/58	€14,248,764	€13,578,624	-€670,140	-4.7%
Formation expenses	20	€1,837	€1,000	-€837	-45.6%
Fixed assets	21/28	€12,290,565	€11,762,731	-€527,835	-4.3%
Intangible fixed assets	21	€2,097,281	€1,757,549	-€339,732	-16.2%
Tangible fixed assets	22/27	€187	€0	-€187	-100%
Other tangible fixed assets	26	€187	€0	-€187	-100%
Financial fixed assets	28	€10,193,097	€10,005,181	-€187,916	-1.8%
Affiliated companies	280/1	€10,193,097	-	-€10.2m
Participating interests	280	€10,193,097	-	-€10.2m
Current assets	29/58	€1,956,362	€1,814,894	-€141,468	-7.2%
Stocks and contracts in progress	3	€0	-	=
Amounts receivable within one year	40/41	€1,948,048	€1,810,513	-€137,536	-7.1%
Trade receivables	40	€1,946,798	€1,718,345	-€228,454	-11.7%
Other amounts receivable	41	€1,250	€92,168	+€90,918	+7,273%
Cash at bank and in hand	54/58	€8,314	€2,700	-€5,614	-67.5%
Deferred charges and accrued income	490/1	-	€1,681	+€1,681
Total equity and liabilities	10/49	€14,248,764	€13,578,624	-€670,140	-4.7%
Equity	10/15	-€901,214	-€992,121	-€90,908	-10.1%
Contributions	10/11	€125,000	€125,000	=	0.0%
Capital	10	€125,000	€125,000	=	0.0%
Issued capital	100	€125,000	€125,000	=	0.0%
Reserves	13	€12,687	€12,687	=	0.0%
Non-distributable reserves	130/1	€12,500	€12,500	=	0.0%
Legal reserve	130	€12,500	€12,500	=	0.0%
Tax-exempt reserves	132	€187	€187	=	0.0%
Profit (loss) carried forward	14	-€1,038,901	-€1,129,808	-€90,908	-8.8%
Amounts payable	17/49	€15,149,978	€14,570,745	-€579,233	-3.8%
Amounts payable after more than one year	17	€11,862,333	€11,364,330	-€498,004	-4.2%
Financial debts	170/4	€2,553,179	€2,055,176	-€498,004	-19.5%
Credit institutions	173	€2,383,179	-	-€2.4m
Other loans	174	€170,000	-	-€170,000
Other amounts payable	178/9	€9,309,154	€9,309,154	=	0.0%
Amounts payable within one year	42/48	€3,287,645	€3,206,416	-€81,229	-2.5%
Current portion of amounts payable after more than one year	42	€492,632	€498,004	+€5,371	+1.1%
Trade debts	44	€68,035	€148,981	+€80,946	+119%
Suppliers	440/4	€68,035	€148,981	+€80,946	+119%
Other amounts payable	47/48	€2,726,978	€2,559,431	-€167,547	-6.1%
Operating income	70/76A	€1,160,736	-	-€1.2m
Turnover	70	€1,121,176	-	-€1.1m
Other operating income	74	€39,479	-	-€39,479
Non-recurring operating income	76A	€81	€0	-€81	-100%
Operating charges	60/66A	€470,427	-	-€470,427
Services and other goods	61	€34,772	-	-€34,772
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets	630	€434,644	€344,006	-€90,638	-20.9%
Provisions for liabilities and charges: additions (uses and reversals)	635/8	€0	-	=
Other operating charges	640/8	€1,010	€1,123	+€113	+11.2%
Non-recurring operating charges	66A	-	€1,250	+€1,250
Gross operating margin	9900	-	€996,862	+€996,862
Operating profit (loss)	9901	€690,309	€650,483	-€39,827	-5.8%
Financial income	75/76B	€325	€0	-€325	-100%
Recurring financial income	75	€325	€0	-€325	-100%
Income from current assets	751	€325	-	-€325
Financial charges	65/66B	€828,601	€741,390	-€87,211	-10.5%
Recurring financial charges	65	€578,601	€553,474	-€25,127	-4.3%
Debt charges	650	€574,921	-	-€574,921
Other financial charges	652/9	€3,680	-	-€3,680
Non-recurring financial charges	66B	€250,000	€187,916	-€62,084	-24.8%
Profit (loss) for the period before taxes	9903	-€137,966	-€90,908	+€47,059	+34.1%
Profit (loss) for the period	9904	-€137,966	-€90,908	+€47,059	+34.1%
Profit (loss) for the period to be appropriated	9905	-€137,966	-€90,908	+€47,059	+34.1%

PHARMACLIC ASSETS: value indication

PHARMACLIC ASSETS: value indication

Position among the sector peers

What moved between 2023 and 2024

Largest movements

Change in the result, 2023 to 2024

Derived cash bridge

Value

Indicative value of the equity

Adjusted equity

Capitalised earnings

Your EBITDA multiple

Limits of the indication

Next steps